SWCNT |
NH2-PEG-COOH, SWCNT-COOH, Aptamer, shRNA, Bcl-xL, PEI |
Expensive method, not applicable for clinical trials, used for the transfection of Bcl-Xl shRNA |
100 |
PEG-NH2, SWCNT-COOH |
Not applicable for clinical trials, used for the transfection of different range of genetic material, non-covalent modifications and attachements |
101 |
TERT siRNA, SWCNT, modified groups -CONH |
Expensive carrier, not easy to produce and scale up, used to transfecr siRNA, used in the suppression of TERT expression approaches |
102 |
Succinate, SWCNT modified with PEI (different kDa’s) |
Chemical bindings to the modifiers were selected, not green approach |
103 |
MAM2 siRNA, DSPE-PEG-Amine functionalized, SWCNT |
Used to transfer siRNA-based genetic material, not green approach, not easy synthesis method |
104 |
hTERT siRNA, SWCNT, NGR peptide, PEI |
Used to transfer siRNA-based genetic material, not green approach, not easy synthesis method |
105 |
MWCNT |
CdTe QDs, PAMAM, MWCNT, PEI, PDDA, Chitosan |
Used electrostatic approach for the gene transfection, not green, not applicable for scale up for clinical trials |
106 |
Glycidyl trimethylammonium chloride siRNA, Dendron, MWCNT |
Used electrostatic and chemical approach for the gene transfection, not green, not applicable for scale up for clinical trials |
107 |
siRNA, PAA, PEI, MWCNT |
Used chemical and physical interaction for the immobalizations, not green, not applicable for clinical trials |
108 |
Cy3, MWCNT, pGL-3, PAA |
Used a novel approach for the intracellular evaluation of the carrier using Cy3 labeled pGL-3 |
109 |
Graphene |
PEI, pDNA, PLGA, oxidized graphene |
Used electrostatic interaction for the gene delivery, Not green, Not applicable for clinical trials |
110 |
Graphene oxide, PEI, PSS, Adriamycin |
Co- and simultaneouse delivery of both anti-miR-21 and Adriamycin, showed acceptable endosomal escape, not easy and green and cost-effective synthesis method |
111 |
Quantum dots, graphene, pDNA, MPG-2H1 chimeric peptide |
Used graphene quantum dots functionalized with not cost-effective linkers, showed successful endosomal escape and cellular nuclear targeting |
112 |
LNA-m-MB, graphene, PEI |
Both chemical and physical interactions, acceptable endosomal escape and transfection efficiency |
113 |
siRNA, EGFP, oxidized graphene |
Great transfection efficiency, not easy to scale up, may have significant cytotoxicity in the clinical trials |
114 |
pCRISPR, EGFP, CoNi2S4, graphene, ZnO |
One-pot and easy synthesis method, acceptable transfection efficiency, acceptable endosomal escape ability, superior stability, can be scale up for clinical trials |
This work |